MYC and diffuse large B-cell lymphoma: DLBCL patients with concomitant BCL2 and MYC abnormalities also had a shorter median PFS (5.0 vs.22.5, p = .002) and OS (9.0 vs.27.5, p = .001) than those without the genetic abnormality.